AAV-PAH

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameAAV-PAH
Drug Alias Namephenylalanine hydroxylase gene therapy (Avigen)AAV-based gene therapy (Avigen)AAV-PAH
ClassificationBiologics
Mechanisms of ActionPhenylalanine hydroxylase agonists
TargetsPhenylalanine hydroxylase
Therapy Area/IndicationsPhenylketonurias
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAvigen Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAvigen Inc
Active IndicationsN/A
Inactive IndicationsPhenylketonurias

Other Information

ATC CodeN/A
Related LinksN/A